Clinical trial
Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
NCT00184652 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184652 |
|---|---|
| Title | Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease |
| Official title | The Effect of Norditropin® on Nutritional Status in Adult Patients in Chronic Haemodialysis |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, End-Stage Renal Disease |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 140 |
| Start date | Apr 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 24, 2017 |
| Countries | Denmark, Germany, Hong Kong, Israel, Poland, Singapore, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: